Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

55.79
Delayed Data
As of Apr 29
 -0.25 / -0.45%
Today’s Change
46.17
Today|||52-Week Range
60.34
-3.94%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues3.7B4.0B4.0B4.2B
 
 
 
 
 
Cost of Goods Sold477.0M477.9M479.8M521.3M
 
 
 
 
 
Depreciation And Amortization98.5M96.4M94.5M147.3M
 
 
 
 
 
 
Operating ExpensesGross Income3.2B3.5B3.4B3.5B
 
 
 
 
 
General Expenses1.5B1.7B1.7B1.9B
 
 
 
 
 
Research And Development482.8M451.7M490.9M585.3M
 
 
 
 
 
Total Operating Expenses2.1B2.2B2.2B2.6B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income1.6B1.8B1.8B1.6B
 
 
 
 
 
Extraordinary Credit353.0M--0.000.00
 
 
Interest Expense On Debt246.1M254.0M276.6M120.3M
 
 
 
 
 
Other Expenses102.6M22.6M35.2M13.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income1.9B1.6B1.5B1.5B
 
 
 
 
 
Income Taxes-387.6M-328.1M-261.7M-298.3M
 
 
 
 
 
Net Income1.5B1.2B1.3B1.2B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.6B2.6B2.6B2.6B
 
 
 
 
 
Shares To Calculate EPS Diluted2.6B2.6B2.6B2.6B
 
 
 
 
 
 
Earnings Per ShareEPS$0.56$0.48$0.49$0.47
 
 
 
 
 
EPS Diluted$0.56$0.48$0.49$0.47